ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 108 filers reported holding ALBIREO PHARMA INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,065,287 | +17.5% | 49,296 | +5.3% | 0.00% | – |
| Q3 2022 | $907,000 | -1.4% | 46,834 | +1.1% | 0.00% | – |
| Q2 2022 | $920,000 | -33.2% | 46,319 | +0.4% | 0.00% | – |
| Q1 2022 | $1,377,000 | +29.1% | 46,147 | +0.8% | 0.00% | – |
| Q4 2021 | $1,067,000 | -23.0% | 45,772 | +3.1% | 0.00% | – |
| Q3 2021 | $1,386,000 | -7.4% | 44,414 | +4.5% | 0.00% | – |
| Q2 2021 | $1,496,000 | -1.0% | 42,504 | -0.8% | 0.00% | -100.0% |
| Q1 2021 | $1,511,000 | -4.2% | 42,841 | +1.9% | 0.00% | 0.0% |
| Q4 2020 | $1,578,000 | +43.3% | 42,059 | +27.5% | 0.00% | 0.0% |
| Q3 2020 | $1,101,000 | +21.0% | 32,982 | -3.9% | 0.00% | – |
| Q2 2020 | $910,000 | +69.5% | 34,329 | +4.8% | 0.00% | – |
| Q1 2020 | $537,000 | -26.0% | 32,753 | +14.8% | 0.00% | – |
| Q4 2019 | $726,000 | +45.2% | 28,532 | +14.2% | 0.00% | – |
| Q3 2019 | $500,000 | -34.3% | 24,983 | +6.0% | 0.00% | – |
| Q2 2019 | $761,000 | +15.5% | 23,576 | +15.3% | 0.00% | – |
| Q1 2019 | $659,000 | +40.5% | 20,440 | +7.0% | 0.00% | – |
| Q4 2018 | $469,000 | -25.6% | 19,099 | 0.0% | 0.00% | – |
| Q3 2018 | $630,000 | -7.2% | 19,099 | 0.0% | 0.00% | – |
| Q2 2018 | $679,000 | – | 19,099 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 480,000 | $14,318,000 | 9.25% |
| Decheng Capital Management III (Cayman), LLC | 518,342 | $15,462,000 | 4.74% |
| TANG CAPITAL MANAGEMENT LLC | 467,702 | $13,952,000 | 2.79% |
| Birchview Capital, LP | 113,000 | $3,371,000 | 2.43% |
| Privium Fund Management B.V. | 351,805 | $10,494,000 | 2.32% |
| Sio Capital Management, LLC | 144,546 | $4,312,000 | 1.43% |
| Perceptive Advisors | 2,360,139 | $70,403,000 | 1.41% |
| Chicago Capital, LLC | 1,011,744 | $30,180,000 | 1.30% |
| Endurant Capital Management LP | 120,834 | $3,604,000 | 0.95% |
| Nicholas Investment Partners, LP | 439,235 | $13,102,000 | 0.93% |